Portola Pharmaceuticals, Inc. to Ring the NASDAQ Stock Market Opening Bell

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ADVISORY, Aug. 2, 2013 (GLOBE NEWSWIRE) -- What: Portola Pharmaceuticals, Inc. [PTLA], a biopharmaceutical company focused on the development and commercialization of novel therapeutics in the areas of blood clots and blood cancers for patients who currently have limited or no approved treatment options, will visit the NASDAQ MarketSite in Times Square.

Help employers find you! Check out all the jobs and post your resume.

Back to news